Jay Giri, MD, MPH is an Interventional Cardiologist, the Associate Director of the Cardiovascular Catheterization Laboratories at the Hospital of the University of Pennsylvania, the Founding Associate Director of the Penn Cardiovascular Outcomes, Quality & Evaluative Research Center, and an Associate Professor at the Perelman School of Medicine.
His clinical interests include complex coronary artery intervention, renal denervation, venous thromboembolism, and aortic valve disease. He performs clinical outcomes and comparative effectiveness research related to emerging endovascular technologies and interventional pharmacotherapies as well as health services and policy research related to cardiovascular medicine. His original research has been published in JAMA, Journal of the American College of Cardiology, and Circulation among others. In 2017, he was selected as one of 12 interventional cardiologists with under 10 years in practice worldwide for the Society for Cardiovascular Angiography & Interventions Emerging Leader Mentorship (ELM) Fellowship. He was the recipient of the 2019 Transcatheter Therapeutics (TCT) Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award, given to one interventional cardiologist worldwide under age 40 for academic and clinical excellence.
Dr. Giri earned a Master’s in Public Health, and a Doctorate in Medicine from Northwestern University. He completed residency in internal medicine at Massachusetts General Hospital and proceeded to complete fellowships in cardiovascular diseases, coronary, and structural heart intervention. He also completed a fellowship in vascular medicine/intervention at the Hospital of the University of Pennsylvania and Massachusetts General Hospital.
